<--- Back to Details
First PageDocument Content
Fertility / Pregnancy / Gynaecology / Abortifacients / Unsafe abortion / Ipas / Reproductive rights / Mifepristone / Medical abortion / Human reproduction / Abortion / Medicine
Date: 2011-09-20 02:54:15
Fertility
Pregnancy
Gynaecology
Abortifacients
Unsafe abortion
Ipas
Reproductive rights
Mifepristone
Medical abortion
Human reproduction
Abortion
Medicine

SRH_1_p11_23.indd

Add to Reading List

Source URL: www.who.int

Download Document from Source Website

File Size: 230,14 KB

Share Document on Facebook

Similar Documents

Стандартные методы обработки шприцев-аспираторов Ipas MVA Plus® и канюль Ipas EasyGrip® ПРИМЕЧАНИЕ: Перед повторным употреблением

DocID: 1vngk - View Document

Отчет О применении шприца-аспиратора Ipas MVA и канюль Plus EasyGrip для профилактики и лечения осложнений после родов и преры

DocID: 1vg0s - View Document

Эвакуация плодного яйца при помощи шприца-аспиратора Ipas MVA Plus и канюль Ipas EasyGrip : ® TM

DocID: 1vf3N - View Document

HRC36: General Debate Item 8 25 September 2017 Joint statement on behalf of Action Canada for Population and Development, Federation for Women and Family Planning, Center for Reproductive Rights, Ipas, [SIGNATORIES WITH

DocID: 1uPWq - View Document

Success Story: iPass Customer Profile: Founded in 1996, iPass (NASDAQ: IPAS) is a leading “Flexera Software is the market leader for a reason,”

DocID: 1t3fk - View Document